AlzeCure Presents New Data Regarding the TrkA-NAM Pain Project at IASP ...
AlzeCure Presents New Data Regarding the TrkA-NAM Pain Project at IASP ...
Stay updated with breaking news from Veronica Lidell. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
AlzeCure Presents New Data Regarding the TrkA-NAM Pain Project at IASP ...
AlzeCure Pharma AB (publ) (FN STO: ALZCUR), a pharmaceutical company that develops candidate drugs for CNS diseases, focusing on Alzheimer's disease and pain, today announced that an abstract on its preclinical project TrkA-NAM against osteoarthritis pain and other severe pain conditions has been accepted for presen...
AlzeCure Gets Late Breaking Abstract of New Preclinical Data with ACD856 ...
AlzeCure gets Presentation Accepted on Disease-Modifying Effects of ...
AlzeCure gets presentation accepted on disease-modifying effects of ACD856 at Alzheimer’s conferenceAlzeCure Pharma AB (publ) (FN STO: ALZCUR), a pharmaceutical company that develops a broad portfolio of small molecule candidate drugs for diseases affecting the central nervous system, with projects in both Alz...